Ardent Health Partners, LLC (NYSE:ARDT) Given Consensus Rating of “Buy” by Brokerages

Shares of Ardent Health Partners, LLC (NYSE:ARDT) have been assigned a consensus rating of “Buy” from the twelve research firms that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $22.00.

ARDT has been the topic of several recent research reports. Stephens reaffirmed an “overweight” rating and set a $24.00 target price on shares of Ardent Health Partners in a research note on Thursday, September 19th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Leerink Partners lifted their target price on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a report on Tuesday, November 12th. Truist Financial cut their price target on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a report on Monday. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research note on Thursday, November 14th.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets acquired a new position in shares of Ardent Health Partners in the third quarter valued at approximately $42,000. Financial Management Professionals Inc. purchased a new position in Ardent Health Partners in the 3rd quarter valued at $50,000. MetLife Investment Management LLC acquired a new position in Ardent Health Partners in the 3rd quarter valued at $135,000. JPMorgan Chase & Co. acquired a new position in Ardent Health Partners in the 3rd quarter valued at $154,000. Finally, Quadrature Capital Ltd acquired a new stake in shares of Ardent Health Partners in the 3rd quarter worth $229,000.

Ardent Health Partners Stock Performance

Shares of Ardent Health Partners stock opened at $16.41 on Thursday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The firm’s 50-day moving average price is $16.66. Ardent Health Partners has a 12 month low of $14.57 and a 12 month high of $20.72.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.